{"id":613495,"date":"2024-06-13T11:05:54","date_gmt":"2024-06-13T15:05:54","guid":{"rendered":"https:\/\/platohealth.ai\/helping-to-bring-cancer-therapies-to-patients-catalyst-clinical-research\/"},"modified":"2024-06-13T12:40:00","modified_gmt":"2024-06-13T16:40:00","slug":"helping-to-bring-cancer-therapies-to-patients-catalyst-clinical-research","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/helping-to-bring-cancer-therapies-to-patients-catalyst-clinical-research\/","title":{"rendered":"\u00a0Helping to bring cancer therapies to patients\u00a0 | Catalyst Clinical Research","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
\n
\n
\n
\n
\n <\/p>\n
\n

\n Andrew Zupnick, PhD <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n

\n June 13, 2024<\/span>\n <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/section>\n

\n

Niche CRO with a difference<\/h2>\n

Catalyst Oncology is a niche Oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to cancer patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our mission because every second counts for patients and their families living with cancer.<\/p>\n

<\/section>\n
\n<\/section>\n

Next-gen Oncology experience<\/h2>\n

Working largely in early- to mid-phase development across a range of both solid and hematologic indications, we understand the nuances of complex study designs, novel endpoints, and cutting-edge technologies.<\/p>\n

<\/figure>\n<\/p><\/div>\n
\n<\/section>\n